Back

Single cell RNA-sequencing of Ewing sarcoma tumors demonstrates transcriptional heterogeneity and clonal evolution.

Goodspeed, A.; Bodlak, A.; Nelson-Taylor, S.; Oike, N.; Shirai, R.; Walker, D.; Porfilio, T. E.; Treece, A.; Black, J. O.; Donaldson, N.; Cost, C.; Garrington, T.; Greffe, B.; Luna-Fineman, S.; Demedis, J.; Lake, J. A.; Danis, E.; Verneris, M. R.; Hayashi, M.

2024-01-20 cancer biology
10.1101/2024.01.18.576251 bioRxiv
Show abstract

Ewing sarcoma is the second most common bone cancer in children, accounting for 2% of pediatric cancer diagnoses. Patients who present with metastatic disease at the time of diagnosis have a dismal prognosis, compared to the >70% 5-year survival of those with localized disease. Here, we utilized single cell RNA-sequencing to characterize the transcriptional landscape of primary Ewing sarcoma tumors and surrounding tumor microenvironment (TME). Copy-number analysis identified subclonal evolution within patients prior to treatment. Primary tumor samples demonstrate a heterogenous transcriptional landscape with several conserved gene expression programs, including those composed of genes related to proliferation and EWS targets. Single cell RNA-sequencing and immunofluorescence of circulating tumor cells at the time of diagnosis identified TSPAN8 as a novel therapeutic target.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.